Phenotypic characteristics of the p.Asn215Ser (p.N215S) GLA mutation in male and female patients with Fabry disease: A multicenter Fabry Registry study

被引:78
作者
Germain, Dominique P. [1 ]
Brand, Eva [2 ]
Burlina, Alessandro [3 ]
Cecchi, Franco [4 ]
Garman, Scott C. [5 ]
Kempf, Judy [6 ]
Laney, Dawn A. [7 ]
Linhart, Ales [8 ]
Marodi, Laszlo [9 ]
Nicholls, Kathy [10 ,11 ]
Ortiz, Alberto [12 ,13 ]
Pieruzzi, Federico [14 ]
Shankar, Suma P. [7 ,15 ]
Waldek, Stephen [16 ]
Wanner, Christoph [17 ]
Jovanovic, Ana [18 ]
机构
[1] Paris Saclay Univ, Univ Versailles, Div Med Genet, Montigny, France
[2] Univ Hosp Munster, Dept Nephrol Hypertens & Rheumatol, Munster, Germany
[3] St Bassiano Hosp, Neurol Unit, Bassano Del Grappa, Italy
[4] Careggi Univ Hosp, Cardiothoracovasc Dept, Referral Ctr Cardiomyopathies, Florence, Italy
[5] Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA
[6] Sanofi Genzyme, Cambridge, MA USA
[7] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA
[8] Charles Univ Prague, Fac Med 1, Dept Cardiovasc Med, Dept Med 2, Prague, Czech Republic
[9] Univ Debrecen, Dept Infect & Pediat Immunol, Debrecen, Hungary
[10] Univ Melbourne, Royal Melbourne Hosp, Dept Nephrol, Parkville, Vic, Australia
[11] Univ Melbourne, Dept Med, Parkville, Vic, Australia
[12] UAM, Sch Med, IIS Fdn Jimenez Diaz, Unidad Dialisis,IRSIN, Madrid, Spain
[13] REDINREN, Madrid, Spain
[14] Univ Milano Bicocca, Dept Med & Surg, Nephrol Unit, Monza, Italy
[15] UC Davis Sch Med, Div Genom Med, Dept Pediat, Sacramento, CA USA
[16] Univ Sunderland, Sunderland, Durham, England
[17] Univ Hosp Wurzburg, Renal Div, Wurzburg, Germany
[18] Salford Royal NHS Fdn Trust, Mark Holland Metab Unit, Salford, Lancs, England
关键词
cardiac variant; Fabry disease; GLA; p; Asn215Ser; N215S; phenotype; ALPHA-GALACTOSIDASE-A; NATURAL-HISTORY DATA; ATYPICAL VARIANT; POINT MUTATIONS; GENE; MANIFESTATIONS; IDENTIFICATION; INVOLVEMENT; CHILDREN; STORAGE;
D O I
10.1002/mgg3.389
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
BackgroundThe p.Asn215Ser or p.N215S GLA variant has been associated with late-onset cardiac variant of Fabry disease. MethodsTo expand on the scarce phenotype data, we analyzed natural history data from 125 p.N215S patients (66 females, 59 males) enrolled in the Fabry Registry (NCT00196742) and compared it with data from 401 patients (237 females, 164 males) harboring mutations associated with classic Fabry disease. We evaluated interventricular septum thickness (IVST), left ventricular posterior wall thickness (LVPWT), estimated glomerular filtration rate and severe clinical events. ResultsIn p.N215S males, mildly abnormal mean IVST and LVPWT values were observed in patients aged 25-34years, and values gradually increased with advancing age. Mean values were similar to those of classic males. In p.N215S females, these abnormalities occurred primarily in patients aged 55-64years. Severe clinical events in p.N215S patients were mainly cardiac (males 31%, females 8%) while renal and cerebrovascular events were rare. Renal impairment occurred in 17% of p.N215S males (mostly in patients aged 65-74years), and rarely in females (3%). Conclusionp.N215S is a disease-causing mutation with severe clinical manifestations found primarily in the heart. Cardiac involvement may become as severe as in classic Fabry patients, especially in males.
引用
收藏
页码:492 / 503
页数:12
相关论文
共 44 条
[1]   Characterization of Classical and Nonclassical Fabry Disease: A Multicenter Study [J].
Arends, Maarten ;
Wanner, Christoph ;
Hughes, Derralynn ;
Mehta, Atul ;
Oder, Daniel ;
Watkinson, Oliver T. ;
Elliott, Perry M. ;
Linthorst, Gabor E. ;
Wijburg, Frits A. ;
Biegstraaten, Marieke ;
Hollak, Carla E. .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2017, 28 (05) :1631-1641
[2]   HGVS Recommendations for the Description of Sequence Variants: 2016 Update [J].
den Dunnen, Johan T. ;
Dalgleish, Raymond ;
Maglott, Donna R. ;
Hart, Reece K. ;
Greenblatt, Marc S. ;
McGowan-Jordan, Jean ;
Roux, Anne-Francoise ;
Smith, Timothy ;
Antonarakis, Stylianos E. ;
Taschner, Peter E. M. .
HUMAN MUTATION, 2016, 37 (06) :564-569
[3]  
Desnick RobertJ., 2001, The Metabolic and Molecular Bases of Inherited Disease, V8th, P3733
[4]   X-chromosome inactivation in female patients with Fabry disease [J].
Echevarria, L. ;
Benistan, K. ;
Toussaint, A. ;
Dubourg, O. ;
Hagege, A. A. ;
Eladari, D. ;
Jabbour, F. ;
Beldjord, C. ;
De Mazancourt, P. ;
Germain, D. P. .
CLINICAL GENETICS, 2016, 89 (01) :44-54
[5]   CARDIOCYTE STORAGE AND HYPERTROPHY AS A SOLE MANIFESTATION OF FABRYS-DISEASE - REPORT ON A CASE SIMULATING HYPERTROPHIC NONOBSTRUCTIVE CARDIOMYOPATHY [J].
ELLEDER, M ;
BRADOVA, V ;
SMID, F ;
BUDESINSKY, M ;
HARZER, K ;
KUSTERMANNKUHN, B ;
LEDVINOVA, J ;
BELOHLAVEK ;
KRAL, V ;
DORAZILOVA, V .
VIRCHOWS ARCHIV A-PATHOLOGICAL ANATOMY AND HISTOPATHOLOGY, 1990, 417 (05) :449-455
[6]   FABRY-DISEASE - 23 MUTATIONS INCLUDING SENSE AND ANTISENSE CPG ALTERATIONS AND IDENTIFICATION OF A DELETIONAL HOT-SPOT IN THE ALPHA-GALACTOSIDASE-A GENE [J].
ENG, CM ;
NIEHAUS, DJ ;
ENRIQUEZ, AL ;
BURGERT, TS ;
LUDMAN, MD ;
DESNICK, RJ .
HUMAN MOLECULAR GENETICS, 1994, 3 (10) :1795-1799
[7]  
ENG CM, 1993, AM J HUM GENET, V53, P1186
[8]   Fluorescence-assisted mismatch analysis (FAMA) for exhaustive screening of the alpha-galactosidase A gene and detection of carriers in Fabry disease [J].
Germain, D ;
Biasotto, M ;
Tosi, M ;
Meo, T ;
Kahn, A ;
Poenaru, L .
HUMAN GENETICS, 1996, 98 (06) :719-726
[9]  
Germain D.P., 2018, NEUROMETABOLIC HERED
[10]   Analysis of left ventricular mass in untreated men and in men treated with agalsidase-β: data from the Fabry Registry [J].
Germain, Dominique P. ;
Weidemann, Frank ;
Abiose, Ademola ;
Patel, Manesh R. ;
Cizmarik, Marta ;
Cole, J. Alexander ;
Beitner-Johnson, Dana ;
Benistan, Karelle ;
Cabrera, Gustavo ;
Charrow, Joel ;
Kantola, Ilkka ;
Linhart, Ales ;
Nicholls, Kathy ;
Niemann, Markus ;
Scott, C. Ronald ;
Sims, Katherine ;
Waldek, Stephen ;
Warnock, David G. ;
Strotmann, Joerg .
GENETICS IN MEDICINE, 2013, 15 (12) :958-965